Jessica Gladwell is one of PW's consultants and patient editors. She has lived with late-stage, chronic Lyme and POTS since circa 2002. She has also served as a caregiver to close family members with late-stage, chronic Lyme. Before diagnosis, she served as a business consultant for a large corporation and PM for a small digital branding agency. Now, she is proactive in the rare and neurological disease community, spreading awareness and advising on matters of health and lifestyle when living with a chronic illness.

    ICYMI: LGS Foundation Press Release- The U.S. Food and Drug Administration (FDA) has approved EPIDIOLEX®

    BOHEMIA, N.Y., June 25, 2018 (LGS Foundation) – The LGS Foundation is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved EPIDIOLEX® (cannabidiol / CBD) for the…

    Continue Reading ICYMI: LGS Foundation Press Release- The U.S. Food and Drug Administration (FDA) has approved EPIDIOLEX®

    American Liver Foundation and Antidote Launch Clinical Trial Matching Tool to Accelerate Liver Disease Research

    NEW YORK (PRWEB) MARCH 13, 2018 – The American Liver Foundation (ALF), the nation’s largest patient advocacy organization for people with liver disease, announced today the launch of an online…

    Continue Reading American Liver Foundation and Antidote Launch Clinical Trial Matching Tool to Accelerate Liver Disease Research
    Close Menu